NHS Pilot Design & Evaluation
Pilots that earn a decision to scale
A pilot charter, the right metrics and an honest evaluation — built to convince NHS governance and procurement.
What you receive
A pilot blueprint
- Pilot charter & objectives
- Metric library
- Governance workplan
- Data-collection design
- Evaluation report
- Scale-up recommendation
The decision a pilot has to win
A pilot is an argument for scaling, evidenced
An NHS pilot is not an end in itself. It exists to answer a single question for the people who decide whether to commission, expand or stop: does this intervention deliver enough benefit, safely enough, to justify investing at scale? When a pilot is designed without that decision in mind, it tends to produce activity data — how many users, how many sessions — rather than the outcome and safety evidence a commissioner actually needs. The result is a project that ran, generated a report, and changed nothing.
We design pilots so that the evidence they produce maps directly onto the scale decision. That starts with a charter that fixes the objective, scope and governance, and a metric set agreed before any data is collected so the goalposts cannot move to flatter the result. It ends with an honest evaluation that a finance, clinical and information-governance audience can all trust. For products built on machine learning, this work pairs naturally with our AI validation and clinical safety service, and for innovators who must then sell the result onward, our explainer on how the NHS buys digital health sets the commercial context.
Inside the blueprint
How we build and run an evaluation
- Charter. We agree the objective, scope, inclusion criteria, governance ownership and the decision the pilot must inform, so everyone knows what success and failure look like before it starts.
- Metrics. We define the outcome, process, safety and experience measures up front, drawing on a tested metric library rather than improvising indicators midway through.
- Data design. We specify what is collected, how, by whom and under what governance, keeping the burden on clinical staff realistic so the data is actually captured.
- Evaluate. We analyse against the agreed metrics and write an evaluation that states limitations plainly — including any null or negative findings.
- Recommend. We give a clear scale, iterate or stop recommendation with the reasoning a governance and procurement audience needs to act on it.
When this service fits
Situations where a structured pilot earns its keep
- You are introducing a new digital tool, device or pathway into NHS use and a board or commissioner will ask for evidence before agreeing to fund it more widely.
- A previous pilot generated usage figures but no credible outcome or safety evidence, and you need the next attempt to actually support a decision.
- You have an AI-enabled product where governance and clinical-safety scrutiny will be intense and the evaluation must withstand it.
- You need an independent, honest evaluation rather than one written by the team with a stake in the outcome.
Pilot design sits within our wider clinical advisory and governance work, and complements audit and quality improvement when you need to measure existing practice before changing it.
From result to rollout
What a credible evaluation unlocks
A well-run evaluation does more than satisfy curiosity about whether something worked. It gives a board the confidence to fund expansion, gives a commissioner the evidence to contract, and gives your own team a clear account of what to change before scaling. Because the metrics were fixed in advance and the analysis is honest about limitations, the conclusion carries weight in the rooms where money and clinical risk are decided — which is precisely where ambiguous pilots fail.
Just as valuable is what a rigorous pilot prevents: scaling something that does not work, or quietly abandoning something that did because the evidence was never gathered to defend it. The evaluation report and scale recommendation become assets you can carry into procurement and commissioning conversations, and they dovetail with the assurance evidence buyers expect — context covered in our NHS buyer readiness guidance and our broader clinical advisory and governance work.
Answers
Frequently asked questions
What makes a pilot credible to NHS decision-makers?
A clear charter (objectives, scope, governance), the right metrics defined before you start, robust data collection, and an honest evaluation with a path to scale. We provide all of these as a pilot blueprint.
Do you evaluate AI pilots specifically?
Yes — combined with our AI validation and governance work for safe, evidenced AI pilots.
How long should an NHS pilot run?
Long enough to gather enough cases for the outcome you are measuring, and to capture seasonal or rota variation that could distort a short snapshot. We set the duration from the metrics and expected event rate rather than picking a round number, and we agree stop and review points up front.
What happens if the pilot does not show benefit?
An honest negative or neutral result is still a useful result, and we report it as such. A pilot that quietly buries disappointing data damages credibility far more than one that explains what was learned and what would need to change before a scale decision.
Who needs to be involved from the NHS side?
A clinical sponsor, an information-governance contact and, where relevant, a clinical safety officer should be engaged early. Defining governance ownership at the charter stage avoids the mid-pilot stall that occurs when approvals are sought too late.
Design your pilot
Tell us the intervention and we'll propose a pilot blueprint.